148 related articles for article (PubMed ID: 6133659)
1. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
Perrild H; Hansen JM; Skovsted L; Christensen LK
Clin Endocrinol (Oxf); 1983 Feb; 18(2):139-42. PubMed ID: 6133659
[TBL] [Abstract][Full Text] [Related]
2. Long-term alprenolol treatment affects serum T4, T3 and rT3 in euthyroid patients with ischaemic heart disease.
Perrild H; Pedersen F; Rasmussen SL; Jürgensen HJ; Skovsted L
Acta Endocrinol (Copenh); 1984 Feb; 105(2):190-3. PubMed ID: 6364669
[TBL] [Abstract][Full Text] [Related]
3. Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism.
Nilsson OR; Karlberg BE; Kågedal B; Tegler L; Almqvist S
Acta Med Scand; 1979; 206(1-2):21-5. PubMed ID: 484256
[TBL] [Abstract][Full Text] [Related]
4. The effect of atenolol on serum thyroid hormones in hyperthyroid patients.
How J; Khir AS; Bewsher PD
Clin Endocrinol (Oxf); 1980 Sep; 13(3):299-302. PubMed ID: 7214722
[TBL] [Abstract][Full Text] [Related]
5. Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease.
Feely J; Isles TE; Ratcliffe WA; Crooks J
Clin Endocrinol (Oxf); 1979 May; 10(5):531-8. PubMed ID: 476982
[TBL] [Abstract][Full Text] [Related]
6. "Low T3-syndrome" in acute myocardial infarction--relationship to beta-adrenergic blockade and clinical course.
Pedersen F; Perrild H; Rasmussen SL; Skovsted L
Eur J Clin Pharmacol; 1984; 26(6):669-73. PubMed ID: 6149125
[TBL] [Abstract][Full Text] [Related]
7. Propranolol and hyperthyroidism: sequential changes in serum iodothyronine (T4, T3, rT3) concentrations during therapy until clinical remission.
Pinho MO; Medeiros YS; Rosenthal D; Francalanci CC
Braz J Med Biol Res; 1983 Jul; 16(2):111-7. PubMed ID: 6652288
[TBL] [Abstract][Full Text] [Related]
8. Serum T4, T3 and reverse T3 during treatment with propranolol in hyperthyroidism, L-T4 treated myxedema and in normal man.
Faber J; Friis T; Kirkegaard C; Lumholtz IB; Hansen JM; Siersbaek-Nielsen K; Skovsted L; Theilade P
Horm Metab Res; 1979 Jan; 11(1):34-6. PubMed ID: 428906
[TBL] [Abstract][Full Text] [Related]
9. The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Frishman WH; Furberg CD; Friedewald WT
Curr Probl Cardiol; 1984 Jun; 9(3):1-50. PubMed ID: 6146495
[No Abstract] [Full Text] [Related]
10. Compared effect of propranolol and acebutolol on serum thyroid hormones' levels in euthyroid and hyperthyroid patients: a randomized study.
Perret G; Hugues JN; Modigliani E; Sebaoun J
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):360-4. PubMed ID: 6469425
[TBL] [Abstract][Full Text] [Related]
11. The influence of propranolol on the extrathyroidal metabolism of 3,3',5'-triiodothyronine (reverse T3).
Lumholtz IB; Busch-Sørensen M; Faber J; Friis T; Kirkegaard C; Siersbaek-Nielsen K
Acta Med Scand Suppl; 1979; 624():31-34. PubMed ID: 284711
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoreceptor blocking drugs and thyroid hormones in hyperthyroid subjects.
Jones MK; Birtwell J; Owens DR; Jones GR; Lewis M
Postgrad Med J; 1981 Apr; 57(666):207-9. PubMed ID: 6117063
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptor blocking drugs in hyperthyroidism.
Turner P
Drugs; 1974; 7(1):48-54. PubMed ID: 4134125
[No Abstract] [Full Text] [Related]
14. The effect of propranolol on circulating thyroid hormone measurements in thyrotoxic and euthyroid subjects.
Franklyn JA; Wilkins MR; Wilkinson R; Ramsden DB; Sheppard MC
Acta Endocrinol (Copenh); 1985 Mar; 108(3):351-5. PubMed ID: 3920853
[TBL] [Abstract][Full Text] [Related]
15. The effect of D- versus L-propranolol in the treatment of hyperthyroidism.
Eber O; Buchinger W; Lindner W; Lind P; Rath M; Klima G; Langsteger W; Költringer P
Clin Endocrinol (Oxf); 1990 Mar; 32(3):363-72. PubMed ID: 2344697
[TBL] [Abstract][Full Text] [Related]
16. The possible reason for serum 3,3'5'-(reverse) triiodothyronine increase in old people.
Szabolcs I; Weber M; Kovács Z; Irsy G; Góth M; Halász T; Szilágyi G
Acta Med Acad Sci Hung; 1982; 39(1-2):11-7. PubMed ID: 7180357
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Shulkin BL; Peele ME; Utiger RD
Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of essential tremor with special reference to the use of beta-blockers].
Gerstenbrand F; Klingler D; Poewe W
Nervenarzt; 1982 Aug; 53(8):435-41. PubMed ID: 6127636
[No Abstract] [Full Text] [Related]
19. Beta blocking agents: current status in the prevention of sudden coronary death.
Hjalmarson A
Ann N Y Acad Sci; 1982; 382():305-23. PubMed ID: 6123286
[No Abstract] [Full Text] [Related]
20. Hyperthyroidism without triiodothyronine excess: an effect of severe non-thyroidal illness.
Engler D; Donaldson EB; Stockigt JR; Taft P
J Clin Endocrinol Metab; 1978 Jan; 46(1):77-82. PubMed ID: 109456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
